TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioglan AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
16,284
|
15,775
|
17,333 |
Financial expenses |
72
|
85
|
187 |
Earnings before taxes |
951
|
1,229
|
2,875 |
EBITDA |
1,477
|
1,649
|
3,656 |
Total assets |
16,970
|
13,683
|
13,066 |
Current assets |
10,945
|
10,624
|
10,573 |
Current liabilities |
7,027
|
3,518
|
3,051 |
Equity capital |
9,943
|
10,005
|
9,195 |
- share capital |
270
|
293
|
299 |
Employees (average) |
101
|
94
|
87 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
58.6%
|
73.1%
|
70.4% |
Turnover per employee |
161
|
168
|
199 |
Profit as a percentage of turnover |
5.8%
|
7.8%
|
16.6% |
Return on assets (ROA) |
6.0%
|
9.6%
|
23.4% |
Current ratio |
155.8%
|
302.0%
|
346.5% |
Return on equity (ROE) |
9.6%
|
12.3%
|
31.3% |
Change turnover |
1,786
|
-1,237
|
-1,655 |
Change turnover % |
12%
|
-7%
|
-9% |
Chg. No. of employees |
7
![]() |
7
|
-6 |
Chg. No. of employees % |
7%
|
8%
|
-6% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.